Literature DB >> 9760120

Secondary inhibition of 2-ketoglutarate dehydrogenase complex by MPTP.

G T Joffe1, J K Parks, W D Parker.   

Abstract

The parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridine (MPP+) acts through inhibition of complex I of the electron transport chain. Recent evidence suggests that it may also act through inhibition of 2-ketoglutarate dehydrogenase complex (KDHC). We confirmed this observation in isolated rat liver mitochondria but found that this inhibition is prevented by preincubation with the radical quencher, cysteine (Cys). KDHC is also inhibited by the NO generator S-nitroso-N-acetyl-penicillamine (SNAP) and this inhibition is similarly blocked by cysteine. MPP+ may inhibit KDHC secondary through a radical-mediated event rather than through direct interaction with KDHC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760120     DOI: 10.1097/00001756-199808240-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease.

Authors:  Gary E Gibson; Saravanan S Karuppagounder; Qingli Shi
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

3.  Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins.

Authors:  Lichuan Yang; Qingli Shi; Daniel J Ho; Anatoly A Starkov; Elizabeth J Wille; Hui Xu; H L Chen; Steven Zhang; Cliona M Stack; Noel Y Calingasan; Gary E Gibson; M Flint Beal
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

Review 4.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 5.  Bioenergetic medicine.

Authors:  Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.